ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.410
-0.080 (-5.37%)
Mar 31, 2025, 1:39 PM EDT - Market open
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $139.71 million as of March 31, 2025. Its market cap has decreased by -56.59% in one year.
Market Cap
139.71M
Enterprise Value
331.93M
1-Year Change
-56.59%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $139.71M, a decrease of -93.16%. That is a compound annual growth rate of -42.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 147.63M | -23.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.94B |
| UnitedHealth Group | 479.94B |
| Johnson & Johnson | 400.18B |
| AbbVie | 371.29B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.08B |
| Merck & Co. | 225.13B |